CD44/CD24 Expression in recurrent gastric cancer: A retrospective analysis

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Yong, Ching Shya ^a   Ou Yang, Chih Ming ^a   Chou, Yenn Hwei ^a   Liao, Chao Sheng ^a   Lee, Chung Wei ^b   Lee, Chin Cheng ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

CD24; CD44; Prognosis; Recurrent gastric cancer

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RECURRENCE RISK; RECURRENT CANCER; RETROSPECTIVE STUDY; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD24; ANTIGENS, CD44; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864191331     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-95     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Nose Y. Risk factors which predict pattern of recurrence after curative surgery for patient with advanced gastric cancer. Surg Oncol 1992, 1:341-346. [PMID: 1341269, 10.1016/0960-7404(92)90034-I, 1341269.
3. Samson PS, Escovidal LA, Yrastorza SG, Veneracion RG, Nerves MY. Re-study of gastric cancer: analysis of outcome. World J Surg 2002, 26:428-433. 10.1007/s00268-001-0243-9, 11910474.
4. Resende C, Thiel A, Machado JC, Ristimäki A. Gastric cancer: Basic aspects. Helicobacter 2011, 16(Suppl 1):38-44.
5. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R, Badve S, Nakshatri H. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006, 8:R59-[PMID: 17062128. 10.1186/bcr165, 1779499, 17062128.
6. Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H. Prevalence of CD44+/CD24/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005, 11:1154-1159.
7. Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, Sima HR, Esmaili-Shandiz E, Hosseinnezhad H, Taghizadeh-Kermani A, Moaven O, Bahrani M. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World J Gastroenterol 2008, 14:6376-6381. PMID: 19009655, 10.3748/wjg.14.6376, 2766121, 19009655.
8. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983, 13:30-34.
9. Idzerda RL, Carter WG, Nottenburg C, Wayner EA, Gallatin WM, St John T. Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Nat Acad Sci 1989, 86:4654-4658. 10.1073/pnas.86.12.4654, 287329, 2471973.
10. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyalouronate-bearing cells. EMBO J 1991, 10(2):343-348. 452652, 1991450.
11. Darwish NS, Kim MA, Change MS, Lee HS, Lee BL, Kim YI, Kim WH. Prognostic significance of CD24 expression in gastric carcinoma. Cancer Res Treat 2004, 36:298-302. 10.4143/crt.2004.36.5.298, 2843873, 20368819.
12. Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH. Cytoplasmic CD24 Expression Is a Novel Prognostic Factor in Diffuse-Type Gastric Adenocarcinoma. Ann Surgl Oncol 2007, 14:2748-2758. PMID: 17680316.
13. Hong RL, Lee WJ, Shun CT, Chu JS, Chen YC. Expression of CD44 and its clinical implication in diffuse- and intestinal-type gastric adenocarcinomas. Oncology 1995, 52:334-339. 10.1159/000227485, 7539903.
14. Kennel SJ, Lankford TK, Foote LJ, Shinpock SG, Stringer C. CD44 expression on murine tissues. J Cell Sci 1993, 104:373-382.
15. Wu K, Nie Y, Guo C, Chen Y, Ding J, Fan D. Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol 2009, 24:37-41. 10.1111/j.1440-1746.2008.05753.x, 19196394.
16. Qiao XT, Gumucio DL. Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J Gastroenterol 2011, 46:855-865. PMID: 21626457, 10.1007/s00535-011-0413-y, 21626457.
17. Zhang C, Li C, He F, Cai Y, Yang H. Identification of CD44 + CD24+ gastric cancer stem cells. J Cancer Res Clin Oncol 2011, 137:1679-1686. [PMID: 21882047, 10.1007/s00432-011-1038-5, 21882047.
18. Bektas S, Bahadir B, Ucan BH, Ozdamar SO. CD24 and Galectin-1 expressions in adenocarinoma and clinicopathologic significance. Pathol Oncol Res 2010, 16:569-577. [PMID: 20177845, 10.1007/s12253-010-9248-8], 20177845.